ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 1266

Time-course Ultrasonography to Predict Flare After Discontinuation of Biologics in Patients with Rheumatoid Arthritis Achieving Stringent Remission

Takehisa Ogura1, Takaharu Katagiri2, Yuto Takakura3, Chihiro Imaizumi4 and Hideto Kameda4, 1Toho university, Meguro-ku, Japan, 2Toho University School of Medicine (Ohashi Medical Center), Division of Rheumatology, Department of Internal Medicine, Tokyo, Japan, 3Toho University, Setagayaku, Japan, 4Toho University, Tokyo, Japan

Meeting: ACR Convergence 2022

Keywords: Imaging, rheumatoid arthritis, Ultrasound

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Imaging of Rheumatic Diseases Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Ultrasonography (US) has been suggested to be useful in predicting flare in patients with rheumatoid arthritis (RA) after discontinuation of biological disease-modifying antirheumatic drugs (bDMARDs). This study aimed to investigate whether US can predict flare after discontinuation of bDMARDs in RA patients who have achieved stringent remission criteria.

Methods: We prospectively enrolled RA patients who maintained a simplified disease activity index ≤ 3.3 and discontinued bDMARDs and measured clinical assessment and US every 2-3 months for 2 years. The US examination was performed on 40 joints using the semi-quantitative method of 0-3 on the Grey-scale (GS) and Power Doppler (PD), and the total values for each patient were used as the GS score and PD score. Joints graded as GS score ≥ 2 or PD score ≥ 1 were counted as US arthritis. In addition, tendons at 36 sites were counted with or without tendinitis/tenosynovitis to obtain a tendon score.

Results: Thirty-six patients were enrolled and two patients who dropped out early without flare were excluded from the comparative analyses. At baseline, the median GS score was 7, PD score was 0, US arthritis was 0, and tendon score was 0. The total PD score was 0 in 26 patients (72%) and it was 1 in 5 patients (14%). There were no significant differences in US findings between the relapse group (20 patients) and the non-relapse group (14 patients). Although a Cox proportional hazards model with baseline US findings showed no significant findings, using a time-dependent Cox proportional hazards model to analyze time-course US findings, the PD score and the tendon score were significant with hazard ratio of 1.14 (95% CI, 1.08-1.21) and 1.37 (95% CI, 1.13-1.66), respectively. However, among the relapse group, 11 in 20 patients (55%) had a PD score of 0 on US finding before relapse.

Conclusion: The US findings suggest that an elevated PD and tendon score are associated with flare after bDMARDs discontinuation, although it is insufficient for the flare prediction.


Disclosures: T. Ogura, AbbVie/Abbott, Bristol-Myers Squibb(BMS), Eli Lilly, Janssen, Eisai, Asahi kasei; T. Katagiri, None; Y. Takakura, None; C. Imaizumi, None; H. Kameda, AbbVie, Asahi-Kasei, Lilly, Janssen, Novartis, Sanofi, Bristol-Myers Squibb, Chugai, Mitsubishi Tanabe, Eisai, Astellas, Gilead, Taisho.

To cite this abstract in AMA style:

Ogura T, Katagiri T, Takakura Y, Imaizumi C, Kameda H. Time-course Ultrasonography to Predict Flare After Discontinuation of Biologics in Patients with Rheumatoid Arthritis Achieving Stringent Remission [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/time-course-ultrasonography-to-predict-flare-after-discontinuation-of-biologics-in-patients-with-rheumatoid-arthritis-achieving-stringent-remission/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/time-course-ultrasonography-to-predict-flare-after-discontinuation-of-biologics-in-patients-with-rheumatoid-arthritis-achieving-stringent-remission/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology